Systematic review and meta-analysis of the efficacy and safety of SGLT2 inhibitors in patients with type 2 diabetes mellitus

Lignende værker

• Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
  af: Karagiannis, T, et al.
  Udgivet: (2012)
• Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.
  af: Vasilakou, D, et al.
  Udgivet: (2013)
• In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes
  af: Ng, SYA, et al.
  Udgivet: (2020)
• Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes
  af: Matthews, DR, et al.
  Udgivet: (2012)
• Safety of metformin in Type 2 diabetes mellitus.
  af: Baigent, C, et al.
  Udgivet: (1999)